Mount Sinai researchers identify promising new drug target for kidney disease
2012-03-12
(Press-News.org) Researchers from Mount Sinai School of Medicine have identified a regulator protein that plays a crucial role in kidney fibrosis, a condition that leads to kidney failure. Finding this regulator provides a new therapeutic target for the millions of Americans affected by kidney failure. The research is published in the March 11 issue of Nature Medicine.
Led by John Cijiang He, MD, PhD, Professor of Nephrology and Pharmacology and Systems Therapeutics; and Avi Ma'ayan, PhD, Assistant Professor of Pharmacology and Systems Therapeutics at Mount Sinai School of Medicine, the research team studied three mouse models of kidney fibrosis: one group of mice contained HIV viral proteins incorporated into their genome; the second group was injected with a high dose of folic acid; in the third mouse model, kidney filtration was blocked in one kidney. All of these factors cause kidney fibrosis.
The researchers gathered the genetic material of the mice and compared it to the genetic material of mice that did not have kidney fibrosis. Using a new computational systems biology algorithm and software called Expression2Kinases—developed by the Ma'ayan Laboratory at Mount Sinai—the results from these experiments were analyzed. They found that HIPK2, a protein kinase, or regulator, was highly active in the mice with kidney fibrosis. HIPK2 regulates the way certain genes are expressed and when HIPK2 is highly active this leads to kidney fibrosis. Drs. He and Ma'ayan also found that when they eliminated HIPK2, fibrosis was less prominent and the condition of the mice significantly improved.
"Our findings have important implications for people with kidney diseases, patients I treat every day," said Dr. He. "Protein kinases like HIPK2 are highly effective therapeutic targets. We look forward to exploring this further."
Incorporating a systems approach allowed the Mount Sinai team to identify a target that is a regulatory protein modified during chronic disease. The high activity of HIPK2 in kidney fibrosis was not identifiable by standard methods that examine gene expression changes alone, but by modeling a network of proteins using computational systems biology, the research team was able to home in on the regulator protein, HIPK2. Now, Mount Sinai scientists can work to develop a drug intervention that inhibits the activity of HIPK2.
"This study is an important example of the translational research we are doing at Mount Sinai," said Dr. Ma'ayan. "Using algorithms and software developed here, we worked with Dr. He, who is a kidney disease physician and scientist, to better understand what causes kidney fibrosis, and we are now one step closer to finding a therapeutic solution to a complex disease that affects millions of Americans."
INFORMATION:
Funding for this study was provided by the National Institute of Diabetes and Digestive and Kidney Diseases, a division of the National Institutes of Health in Bethesda, Md.
END
ELSE PRESS RELEASES FROM THIS DATE:
2012-03-12
MARSEILLES, FRANCE -- As food and energy production intensify around the world, their demands on dwindling water resources have prompted the search for an innovative and collaborative solution. On Friday, March 16, a High Level Panel convened by the EDF Group and the CGIAR Challenge Program on Water and Food (CPWF) will gather in Marseilles at the Sixth World Water Forum (WWF6) to share experiences and results.
The panel will discuss how to embrace a "nexus" approach to water management, in which projects that tap water resources are planned and executed with input from ...
2012-03-12
DURHAM, N.C. – A team of researchers at Duke University has determined the structure of a key molecule that can carry chemotherapy and anti-viral drugs into cells, which could help to create more effective drugs with fewer effects to healthy tissue.
"Knowing the structure and properties of the transporter molecule may be the key to changing the way that some chemotherapies, for example, could work in the body to prevent tumor growth," said senior author Seok-Yong Lee, Ph.D., assistant professor of biochemistry at Duke.
The article was published in Nature online on ...
2012-03-12
A team of Australian scientists has bred salt tolerance into a variety of durum wheat that shows improved grain yield by 25% on salty soils.
Using 'non-GM' crop breeding techniques, scientists from CSIRO Plant Industry have introduced a salt-tolerant gene into a commercial durum wheat, with spectacular results shown in field tests. Researchers at the University of Adelaide's Waite Research Institute have led the effort to understand how the gene delivers salinity tolerance to the plants.
The research is the first of its kind in the world to fully describe the improvement ...
2012-03-12
The Greenland ice sheet is likely to be more vulnerable to global warming than previously thought. The temperature threshold for melting the ice sheet completely is in the range of 0.8 to 3.2 degrees Celsius global warming, with a best estimate of 1.6 degrees above pre-industrial levels, shows a new study by scientists from the Potsdam Institute for Climate Impact Research (PIK) and the Universidad Complutense de Madrid. Today, already 0.8 degrees global warming has been observed. Substantial melting of land ice could contribute to long-term sea-level rise of several meters ...
2012-03-12
In a study released today in Nature Genetics, researchers have found that Chlamydia has evolved more actively than was previously thought. Using whole genome sequencing the researchers show that the exchange of DNA between different strains of Chlamydia to form new strains is much more common than expected.
The team highlights that current clinical testing methods do not capture the variation between Chlamydia strains. Changes to the genome structure are not the aim of current diagnostics for Chlamydia. The researchers are working with hospitals to use their results ...
2012-03-12
Hospitals in Arizona and across the country are burying their mistakes, according to a new study recently released by U.S. Department of Health and Human Services Inspector General Daniel R. Levinson. The study found that 15,000 Medicare patients die every month in part due to inadequate treatment in hospitals. The types of medical malpractice detailed in the study are gruesome and include surgical fires, objects left inside patients after surgery and surgeries performed on the wrong patients. If your loved one has died due to hospital negligence, you need to speak with ...
2012-03-12
Researchers from Queen Mary, University of London and the University of Surrey have found a protein inside blood vessels with an ability to protect the body from substances which cause cardiovascular disease.
The findings, published online in the journal Cardiovascular Research, have revealed the protein protein pregnane X receptor (PXR) can switch on different protective pathways in the blood vessels.
Co-author Dr David Bishop-Bailey, based at Queen Mary's William Harvey Research Institute, said they found the protein was able to sense a wide variety of drugs, foreign ...
2012-03-12
NEW YORK, NY -- A study by Columbia researchers suggests that cells in the patient's intestine could be coaxed into making insulin, circumventing the need for a stem cell transplant. Until now, stem cell transplants have been seen by many researchers as the ideal way to replace cells lost in type I diabetes and to free patients from insulin injections.
The research—conducted in mice—was published 11 March 2012 in the journal Nature Genetics.
Type I diabetes is an autoimmune disease that destroys insulin-producing cells in the pancreas. The pancreas cannot replace these ...
2012-03-12
Medical professionals have long thought that traumatic brain injuries do not affect young children as significantly as they do adults. Two new studies, however, suggest otherwise. Young children suffering from severe traumatic brain injuries (TBI) may actually suffer continued impairment later in life than experts first thought.
The studies yielded important new information on childhood traumatic brain injuries. Children who suffered severe traumatic brain injuries, for example, had slower intellectual functioning, showing that the traumatic brain injury may have affected ...
2012-03-12
A retinoid called all-trans retinoic acid (ATRA), which is a vitamin A-derivative, is already used successfully to treat a rare sub-type of acute myeloid leukemia (AML), however this drug has not been effective for the more common types of AMLs.
Team leader Arthur Zelent, Ph.D., and colleagues at the ICR have been working to unlock the potential of retinoids to treat other patients with AML. In a paper published in Nature Medicine today, they show that the key could be an antidepressant called tranylcypromine (TCP).
"Retinoids have already transformed one rare type ...
LAST 30 PRESS RELEASES:
[Press-News.org] Mount Sinai researchers identify promising new drug target for kidney disease
